Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Former Ranbaxy Director arrested for selling mortgage property

      Former Ranbaxy Director arrested for selling mortgage property

      Ruby Khatun Khatun29 Oct 2017 10:31 AM IST
      New Delhi: The Economic Offences Wing of the Delhi Police arrested a 65-year-old man for allegedly trying to sell a property mortgaged to a bank, the...
      Nightingales collaborates with Amplifon to bring hearing home

      Nightingales collaborates with Amplifon to bring hearing home

      Ruby Khatun Khatun29 Oct 2017 10:28 AM IST
      Bangalore: Nightingales Home Health Services has announced its association with Amplifon.Amplifon provides the latest technology-enabled digital...
      US committee recommends GSK shingles vaccine over Merck rival

      US committee recommends GSK shingles vaccine over Merck rival

      Ruby Khatun Khatun29 Oct 2017 9:44 AM IST
      LONDON: The committee responsible for U.S. vaccination schedules have given a preferential recommendation for GlaxoSmithKline’s (GSK) newly approved...
      GlaxoSmithKline Pharma Q2 net profit up 32 percent at Rs 130 cr

      GlaxoSmithKline Pharma Q2 net profit up 32 percent at Rs 130 cr

      Ruby Khatun Khatun28 Oct 2017 9:46 AM IST
      New Delhi: Drug firm GlaxoSmithKline Pharmaceuticals reported a 31.83 percent rise in standalone net profit to Rs 130.32 crore for the second quarter...
      FDA approves intravenous version of Tesaro drug for chemotherapy nausea

      FDA approves intravenous version of Tesaro drug for chemotherapy nausea

      Ruby Khatun Khatun28 Oct 2017 9:44 AM IST
      Tesaro Inc said on Wednesday that the U.S. Food and Drug Administration (FDA) approved an intravenous version of its drug to treat...
      Teva accuses Lilly in US court of infringing migraine drug patents

      Teva accuses Lilly in US court of infringing migraine drug patents

      Ruby Khatun Khatun27 Oct 2017 9:36 AM IST
      BOSTON: Teva Pharmaceutical Industries Ltd has filed a patent infringement lawsuit seeking to block Eli Lilly and Co from bringing its migraine drug...
      GSK ready to build drug testing in EU as Brexit looms

      GSK ready to build drug testing in EU as Brexit looms

      Ruby Khatun Khatun27 Oct 2017 9:36 AM IST
      LONDON: Britain’s biggest drugmaker GlaxoSmithKline (GSK) is moving ahead with Brexit contingency planning “right now”, including preparing a system...
      Trouble mounts for ELDER Pharma with the passing of MD

      Trouble mounts for ELDER Pharma with the passing of MD

      Ruby Khatun Khatun26 Oct 2017 5:35 PM IST
      MUMBAI: The demise of the Managing Director and Chief Executive Officer Alok Saxena of Elder Pharmaceuticals recently has indeed brought more trouble...
      Reject pressure to review price control on medical devices: Body Tells Govt

      Reject pressure to review price control on medical devices: Body Tells Govt

      Ruby Khatun Khatun26 Oct 2017 1:48 PM IST
      New Delhi: The government should reject any pressure to review price control on medical devices by the US-based medical device industry, the All India...
      NeuroPace raises 74 million dollars to market seizure-monitoring device

      NeuroPace raises 74 million dollars to market seizure-monitoring device

      Ruby Khatun Khatun26 Oct 2017 10:00 AM IST
      NeuroPace Inc said on Tuesday it raised $74 million in equity funding as the medical device maker looks to rapidly expand commercialization of its...
      Glenmark launches oral drug for Psoriasis treatment in India

      Glenmark launches oral drug for Psoriasis treatment in India

      Ruby Khatun Khatun26 Oct 2017 9:52 AM IST
      New Delhi: Glenmark Pharmaceuticals said it has launched Apremilast, the first advanced oral systemic treatment for Psoriasis in India.Apremilast,...
      Janssen gets FDA approval for Golimumab to treat active psoriatic arthritis, active ankylosing spondylitis

      Janssen gets FDA approval for Golimumab to treat active psoriatic arthritis, active ankylosing spondylitis

      Ruby Khatun Khatun26 Oct 2017 9:35 AM IST
      HORSHAM, Pa.: Janssen Biotech, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved SIMPONI ARIA® (golimumab), the only...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok